Prostatis Group’s iShares 5-10 Year Investment Grade Corporate Bond ETF IGIB Stock Holding History
Bought
Maintained
Sold
Other funds holding IGIB
AC
OCM
Prostatis Group's IGIB Position: Q2 2026 in Review
Prostatis Group reduced its iShares 5-10 Year Investment Grade Corporate Bond ETF (IGIB) stake by 9.1% in Q2 2026, selling an estimated $22K and leaving 4,155 shares worth $221K. The position accounts for 0.05% of the portfolio, ranked #174.
Prostatis Group first reported a position in IGIB in Q1 2020 and has held it in 16 quarters since. The position peaked at $4.56M in Q1 2020. 709 funds tracked by Wall St. Rank hold IGIB as of Q2 2026.
- Prostatis Group held 4,155 shares of iShares 5-10 Year Investment Grade Corporate Bond ETF worth $221K as of Q2 2026.
- Prostatis Group sold 414 iShares 5-10 Year Investment Grade Corporate Bond ETF shares in Q2 2026, an estimated $22K.
- iShares 5-10 Year Investment Grade Corporate Bond ETF made up 0.05% of Prostatis Group's portfolio in Q2 2026, its #174 holding.
- Prostatis Group first reported a position in iShares 5-10 Year Investment Grade Corporate Bond ETF in Q1 2020 and has held it in 16 quarters since.
- Prostatis Group's iShares 5-10 Year Investment Grade Corporate Bond ETF position peaked at $4.56M in Q1 2020.
- 709 funds tracked by Wall St. Rank held iShares 5-10 Year Investment Grade Corporate Bond ETF as of Q2 2026.
Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.